It would be interesting to see if double expressing ABC-DLBCL also harbor a MYD88 mutation or TNFAIP3 loss or both together since our data indicate that both genetic aberrations contribute to BCL2 and MYC expression in ABC-DLBCL. Here, MYD88 is linked to diffuse large B-cell lymphoma.